Table of Content

Chapter 1 About the Therapeutic Vaccines Industry
1.1 Industry Definition
1.1.1 Types of Therapeutic Vaccines industry
1.2.1.1 Peptide therapeutic vaccine
1.2.1.2 Cell therapeutic vaccine
1.2.1.3 Nucleic acid therapeutic vaccine
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape
2.1 Therapeutic Vaccines Markets by regions
2.1.1 USA
Market Revenue and Growth 2012-2017
Market overview
Major players Revenue in 2016
2.1.2 Europe
Market Revenue and Growth 2012-2017
Market overview
Major players Revenue in 2016
2.1.3 China
Market Revenue and Growth 2012-2017
Market overview
Major players Revenue in 2016
2.1.4 Japan
Market Revenue and Growth 2012-2017
Market overview
Major players Revenue in 2016
2.1.5 India
Market Revenue and Growth 2012-2017
Market overview
Major players Revenue in 2016
2.2 World Therapeutic Vaccines Market by types
Peptide therapeutic vaccine
Cell therapeutic vaccine
Nucleic acid therapeutic vaccine
2.3 World Therapeutic Vaccines Market by Applications
hospital
clinic
others
Chapter 3 World Therapeutic Vaccines Market share
3.1 Major players Market share by production
3.2 Major players Market share by Revenue
3.3 Major Regions Market share by Production in 2016, Through 2022
3.4 Major Regions Market share By Revenue in 2016, Through 2022
Chapter 4 Supply Chain
4.1 Industry Supply chain Analysis
4.2 Raw material Market analysis
4.2.1 Raw material Prices analysis 2012-2016
4.2.2 Raw material Supply Market analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis
Chapter 5 Company Profiles
5.1 DCVax-Brain
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue, Price and Operating Profits
5.2 Oncophase
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue, Price and Operating Profits
5.3 OncoVax
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue, Price and Operating Profits
5.4 CIMAVAX
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue, Price and Operating Profits
5.5 Provenge
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue, Price and Operating Profits
Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry
Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by regions
7.2 Major Customers and contact information by regions
Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 India
8.5 Japan
Chapter 9 World Therapeutic Vaccines Market Forecast through 2022
9.1 World Therapeutic Vaccines Demand by Regions Forecast through 2022
9.2 World Therapeutic Vaccines Price(by Regions, Types, Applications)Analysis Forecast through 2022
9.3 World Therapeutic Vaccines Revenue(by Regions, Types, Applications) Forecast through 2022
Chapter 10 Key success factors and Market Overview

Tables and figures
Table Main Market Activities by Regions
Table Market Revenue and Growth 2012-2017
Table Major players Revenue in 2016
Table Market Revenue and Growth 2012-2017
Table Major players Revenue in 2016
Table Market Revenue and Growth 2012-2017
Table Major players Revenue in 2016
Table Market Revenue and Growth 2012-2017
Table Major players Revenue in 2016
Table Market Revenue and Growth 2012-2017
Table Major players Revenue in 2016
Table Major players Market share by production 2017
Table Major players Market share by Revenue 2017
Table Major Regions Market share by Production in 2016-2016
Table Major Regions Market share by Production in 2017-2022
Table Major Regions Market share by Revenue in 2016-2016
Table Major Regions Market share by Revenue in 2017-2022
Table Industry Supply chain Analysis
Table Raw material Prices analysis 2012-2016
Table Raw material Suppliers Market analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by regions
Table DCVax-Brain Information List
Figure Therapeutic VaccinesTherapeutic Vaccines Picture, Specifications and Applications of DCVax-Brain
Table Therapeutic Vaccines Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of DCVax-Brain 2017
Figure Therapeutic Vaccines Sales Volume (K doses) and World Market Share of DCVax-Brain 2016
Table Oncophase Information List
Figure Therapeutic Vaccines Picture, Specifications and Applications of Oncophase
Table Therapeutic Vaccines Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Oncophase 2017
Figure Therapeutic Vaccines Sales Volume (K doses) and World Market Share of Oncophase 2017
Table OncoVax Information List
Figure Therapeutic Vaccines Picture, Specifications and Applications of OncoVax
Table Therapeutic Vaccines Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of OncoVax 2017
Figure Therapeutic Vaccines Sales Volume (K doses) and World Market Share of OncoVax 2017
Table CIMAVAX Information List
Figure Therapeutic Vaccines Picture, Specifications and Applications of CIMAVAX
Table Therapeutic Vaccines Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of CIMAVAX 2017
Figure Therapeutic Vaccines Sales Volume (K doses) and World Market Share of CIMAVAX 2017
Table Provenge Information List
Figure Therapeutic Vaccines Picture, Specifications and Applications of Provenge
Table Therapeutic Vaccines Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Provenge 2017
Figure Therapeutic Vaccines Sales Volume (K doses) and World Market Share of Provenge 2017
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by regions
Table Major Customers and contact information by regions
Table USA Supply, Import, Export, Consumption (K doses) and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption(K doses) and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption(K doses) and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption(K doses) and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption(K doses) and Consumption Value(M USD)
Table World Demand (K doses) by Regions Forecast Analysis of Therapeutic Vaccines (2016-2022)
Table World Price by Regions Forecast Analysis of Therapeutic Vaccines (2016-2022)
Table World Price by Types Forecast Analysis of Therapeutic Vaccines (2016-2022)
Table World Price by Applications Forecast Analysis of Therapeutic Vaccines (2016-2022)
Table World Revenue by Regions Forecast Analysis of Therapeutic Vaccines (2016-2022)
Table World Revenue (M USD) by Types Forecast Analysis of Therapeutic Vaccines (2016-2022)
Table World Revenue (M USD) by Applications Forecast Analysis of Therapeutic Vaccines (2016-2022)